Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1993 Summer;4(2):89-96.
doi: 10.1007/BF02782121.

Regional and developmental variations of GFAP and actin mRNA levels in the CNS of jimpy and shiverer mutant mice

Affiliations
Comparative Study

Regional and developmental variations of GFAP and actin mRNA levels in the CNS of jimpy and shiverer mutant mice

H Chen et al. J Mol Neurosci. 1993 Summer.

Abstract

Gliosis is a common reaction to brain damage. Glial fibrillary acidic protein (GFAP) is a classical astrocytic marker. We have undertaken to measure the level of GFAP-mRNA as an index of gliosis in the brain of jimpy (jp) and shiverer (shi) murine mutants, in which hypomyelination is either severe or moderate, respectively. This study was conducted in five different CNS regions and at different ages. In young jp mutant, the amount of GFAP-mRNA was either normal or lower than in control animals; but after 3 wk of age, the level of GFAP-transcript increased dramatically in all regions examined. A parallel increase in actin-mRNA was also observed, mostly in the diencephalon and to a lesser extent in cortex and spinal cord, but not in the cerebellum and brainstem. In the shi mutant, variations in the amount of GFAP-mRNA were less important than in the jp with two exceptions: In brainstem of 3-wk-old animals, a 2.5-fold increase was observed, and in all the regions but the spinal cord of 12-d-old shi, the levels of GFAP-transcript were 2-5 times lower than in controls. In this mutant, the levels of actin message were usually close to normal, or slightly lower than in controls.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neurosci Lett. 1979 Apr;12(1):113-8 - PubMed
    1. Nature. 1980 Jan 10;283(5743):207-10 - PubMed
    1. J Neurochem. 1985 Aug;45(2):572-80 - PubMed
    1. J Neurosci Res. 1981;6(3):303-13 - PubMed
    1. FEBS Lett. 1987 Nov 2;223(2):417-21 - PubMed

Publication types

MeSH terms

LinkOut - more resources